Predictors for Progression of Tricuspid Insufficiency Following Left-Sided Valvular Surgery: A Retrospective Cohort Study
DOI:
https://doi.org/10.1532/hsf.2395Abstract
Background: The operative indications for severe tricuspid insufficiency in patients undergoing left-sided valvular surgery are well defined; however, for mild and moderate insufficiency, the findings are still controversial. In this study, we aimed to document the prognostic parameters for progression of tricuspid insufficiency in patients undergoing left-sided valvular surgery.
Methods: 135 patients undergoing mitral valve ± coronary bypass surgery were retrospectively examined. Patients with simultaneous tricuspid valve surgery were excluded. Demographic, clinical, and laboratory findings were recorded and the relationship with progression of tricuspid insufficiency was studied.
Results: Valvular pathology was rheumatic in origin in 72.6% of patients. Tricuspid insufficiency was progressed in 69 (51.1%) of patients, while it did not change in 66 (48.9%) patients. Echocardiographic parameters recorded during follow-up revealed that left ventricular end-diastolic diameter decreased, while there was no significant change in right ventricular end-diastolic diameter. Tricuspid insufficiency was directly related with right ventricular end-diastolic diameter (P < .05), while no relationship was documented with left ventricular end-diastolic diameter. There was a statistically significant correlation between postoperative progression of tricuspid insufficiency and left atrial diameter; however, no relationship was documented with age, sex, valvular disease etiology, comorbidities, or preoperative atrial fibrillation. Risk factor analysis revealed that left atrial diameter was the only prognostic factor.
Conclusion: The indications for mild and moderate tricuspid insufficiency are still not clear for patients undergoing left-sided valvular surgery. In this study, we documented that left atrial dilatation was a prognostic factor for progression of postoperative tricuspid insufficiency. In this group of patients, presence of left atrial dilatation may be an indication for tricuspid valve intervention.
References
Abe Y, Akamatsu K, Ito K, et al. 2018. Prevalence and prognostic significance of functional mitral and tricuspid regurgitation despite preserved left ventricular ejection fraction in atrial fibrillation patients. Circ J 82:1451-8.
Baumgartner H, Falk W, Bax J, et al. 2017. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739-91.
Beckhoff F, Alushi B, Jung C, et al. 2018. Tricuspid regurgitation–medical management and evolving interventional concepts. Front Cardiovasc Med 5:49.
Bianchi G, Solinas M, Bevilacqua S, Glauber M. 2009. Which patient undergoing mitral valve surgery should also have the tricuspid repair? Interact Cardiovasc Thorac Surg 9:1009-20.
Chan KM, Zakkar M, Amirak E, Punjabi PP. 2009. Tricuspid valve disease: pathophysiology and optimal management. Prog Cardiovasc Dis 51:482-6.
Desai RR, Vargas Abello LM, Klein AL, et al. 2013. Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure. J Thorac Cardiovasc Surg 146:1126-32.
Gürsoy M, Bakuy V, Hatemi AC, et al. 2014. Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement. Anatol J Cardiol 14:34-9.
Kammerlander AA, Marzluf BA, Graf A, et al. 2014. Right ventricular dysfunction, but not tricuspid regurgitation, is associated with outcome late after left heart valve procedure. J Am Coll Cardiol 64:2633-42.
Kara I, Koksal C, Erkin A, et al. 2015. Outcomes of mild to moderate functional tricuspid regurgitation in patients undergoing mitral valve operations: A meta-analysis of 2,488 patients. Annals Thorac Surg 100:2398-2407.
Kusajima K, Fujita T, Hata H, Shimahara Y, Miura S, Kobayashi J. 2016. Long-term echocardiographic follow-up of untreated 2+ functional tricuspid regurgitation in patients undergoing mitral valve surgery. Interact Cardiovasc Thorac Surg 23:96-103.
Pagnesi M, Montalto C, Mangieri A, et al. 2017. Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis. Int J Cardiol 240:138-44.
Popal MS, Fu JT, Hu QM, Luo TG, Zheng S, Meng X. 2018. Intraoperative method based on tricuspid annular circumference in patients with mild or no tricuspid regurgitation during left-sided cardiac valve surgery for the prophylactic tricuspid annuloplasty. J Thorac Dis 10:3670-8.
Ro SK, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. 2013. Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg 146:1092-7.
Takano H, Miramatsu M, Kida H, et al. 2017. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today 47:445-56.
Vahanian A, Brochet E, Juliard JM. 2018. Guidelines recommendations on the treatment of tricuspid regurgitation. Where are we and where do we go with transcatheter valve intervention. Front Cardiovasc Med 5:37.
Yajima S, Yoshioka D, Toda K, et al. 2018. Definitive determinant of late significant tricuspid regurgitation after aortic valve replacement. Circ J 82:886-94.
